CG
IMNM icon

Cutler Group’s Immunome IMNM Stock Holding History

Cutler Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-600
Closed -$4K – 4032
2023
Q2 		$4K Buy
+600
New +$3.28K ﹤0.01% 2722
2021
Q4 		– Sell
-719
Closed -$17K – 5692
2021
Q3 		$17K Buy
+719
New +$12.5K ﹤0.01% 3490

Other funds holding IMNM

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cutler Group's IMNM Position: Q3 2023 in Review

Cutler Group sold out of Immunome (IMNM) in Q3 2023, closing a stake of 600 shares — an estimated $4K sold.

Cutler Group first reported a position in IMNM in Q3 2021 and held it in 2 quarters. The position peaked at $17K in Q3 2021. 35 funds tracked by Wall St. Rank hold IMNM as of Q3 2023.

  • Cutler Group reported no remaining Immunome position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 600 Immunome shares in Q3 2023, an estimated $4K.
  • Cutler Group first reported a position in Immunome in Q3 2021 and held it in 2 quarters.
  • Cutler Group's Immunome position peaked at $17K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held Immunome as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.